Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study.

Frey N, Linke A, Süselbeck T, Müller-Ehmsen J, Vermeersch P, Schoors D, Rosenberg M, Bea F, Tuvia S, Leor J.

Circ Cardiovasc Interv. 2014 Dec;7(6):806-12. doi: 10.1161/CIRCINTERVENTIONS.114.001478. Epub 2014 Oct 28.

PMID:
25351198
2.

A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms.

Tuvia S, Pelled D, Marom K, Salama P, Levin-Arama M, Karmeli I, Idelson GH, Landau I, Mamluk R.

Pharm Res. 2014 Aug;31(8):2010-21. doi: 10.1007/s11095-014-1303-9. Epub 2014 Feb 21.

3.

Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppression.

Tuvia S, Atsmon J, Teichman SL, Katz S, Salama P, Pelled D, Landau I, Karmeli I, Bidlingmaier M, Strasburger CJ, Kleinberg DL, Melmed S, Mamluk R.

J Clin Endocrinol Metab. 2012 Jul;97(7):2362-9. doi: 10.1210/jc.2012-1179. Epub 2012 Apr 26.

PMID:
22539587
4.

The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.

Alchanati I, Teicher C, Cohen G, Shemesh V, Barr HM, Nakache P, Ben-Avraham D, Idelevich A, Angel I, Livnah N, Tuvia S, Reiss Y, Taglicht D, Erez O.

PLoS One. 2009 Dec 1;4(12):e8104. doi: 10.1371/journal.pone.0008104.

5.

Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.

Leor J, Tuvia S, Guetta V, Manczur F, Castel D, Willenz U, Petneházy O, Landa N, Feinberg MS, Konen E, Goitein O, Tsur-Gang O, Shaul M, Klapper L, Cohen S.

J Am Coll Cardiol. 2009 Sep 8;54(11):1014-23. doi: 10.1016/j.jacc.2009.06.010.

6.

Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin.

Brin YS, Golenser J, Mizrahi B, Maoz G, Domb AJ, Peddada S, Tuvia S, Nyska A, Nyska M.

J Control Release. 2008 Oct 21;131(2):121-7. doi: 10.1016/j.jconrel.2008.07.022. Epub 2008 Jul 20.

7.

The ubiquitin E3 ligase POSH regulates calcium homeostasis through spatial control of Herp.

Tuvia S, Taglicht D, Erez O, Alroy I, Alchanati I, Bicoviski V, Dori-Bachash M, Ben-Avraham D, Reiss Y.

J Cell Biol. 2007 Apr 9;177(1):51-61.

8.

The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production.

Alroy I, Tuvia S, Greener T, Gordon D, Barr HM, Taglicht D, Mandil-Levin R, Ben-Avraham D, Konforty D, Nir A, Levius O, Bicoviski V, Dori M, Cohen S, Yaar L, Erez O, Propheta-Meiran O, Koskas M, Caspi-Bachar E, Alchanati I, Sela-Brown A, Moskowitz H, Tessmer U, Schubert U, Reiss Y.

Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1478-83. Epub 2005 Jan 19.

9.

Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding.

Amit I, Yakir L, Katz M, Zwang Y, Marmor MD, Citri A, Shtiegman K, Alroy I, Tuvia S, Reiss Y, Roubini E, Cohen M, Wides R, Bacharach E, Schubert U, Yarden Y.

Genes Dev. 2004 Jul 15;18(14):1737-52.

10.

Expression of small heat shock protein alphaB-crystallin is induced after hepatic stellate cell activation.

Lang A, Schrum LW, Schoonhoven R, Tuvia S, Solís-Herruzo JA, Tsukamoto H, Brenner DA, Rippe RA.

Am J Physiol Gastrointest Liver Physiol. 2000 Dec;279(6):G1333-42.

11.

Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells.

Lang A, Schoonhoven R, Tuvia S, Brenner DA, Rippe RA.

J Hepatol. 2000 Jul;33(1):49-58.

PMID:
10905586
12.

Abnormal cardiac Na(+) channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice.

Chauhan VS, Tuvia S, Buhusi M, Bennett V, Grant AO.

Circ Res. 2000 Mar 3;86(4):441-7.

PMID:
10700449
13.

Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins.

Tuvia S, Buhusi M, Davis L, Reedy M, Bennett V.

J Cell Biol. 1999 Nov 29;147(5):995-1008.

14.

Beta-adrenergic agonists regulate cell membrane fluctuations of human erythrocytes.

Tuvia S, Moses A, Gulayev N, Levin S, Korenstein R.

J Physiol. 1999 May 1;516 ( Pt 3):781-92.

15.

Mechanical fluctuations of the membrane-skeleton are dependent on F-actin ATPase in human erythrocytes.

Tuvia S, Levin S, Bitler A, Korenstein R.

J Cell Biol. 1998 Jun 29;141(7):1551-61.

16.
17.

Cell membrane fluctuations are regulated by medium macroviscosity: evidence for a metabolic driving force.

Tuvia S, Almagor A, Bitler A, Levin S, Korenstein R, Yedgar S.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5045-9.

19.

Atrial natriuretic peptide: direct effects on human red blood cell dynamics.

Zamir N, Tuvia S, Riven-Kreitman R, Levin S, Korenstein R.

Biochem Biophys Res Commun. 1992 Nov 16;188(3):1003-9.

PMID:
1445336
20.
21.

Supplemental Content

Support Center